|
?:authorAffiliation
|
-
[\'Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. xuxie@UTMB.edu.\', \'Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.\', \'Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.\', \'Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.\', \'Gilead Sciences, Inc., Foster City, CA, USA.\', \'Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.\', \'Gilead Sciences, Inc., Foster City, CA, USA. john.bilello@gilead.com.\', \'Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.\', \'Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.\', \'Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.\', \'Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}